SCA
CLB icon

Southpoint Capital Advisors’s Core Laboratories CLB Stock Holding History

Southpoint Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-188,368
Closed -$5.96M – 47
2022
Q1 		$5.96M Buy
+188,368
New +$5.28M 0.12% 50

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Southpoint Capital Advisors's CLB Position: Q2 2022 in Review

Southpoint Capital Advisors sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 188,368 shares — an estimated $5.96M sold.

Southpoint Capital Advisors first reported a position in CLB in Q1 2022 and held it in 1 quarter. The position peaked at $5.96M in Q1 2022. 176 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • Southpoint Capital Advisors reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • Southpoint Capital Advisors sold 188,368 Core Laboratories shares in Q2 2022, an estimated $5.96M.
  • Southpoint Capital Advisors first reported a position in Core Laboratories in Q1 2022 and held it in 1 quarter.
  • Southpoint Capital Advisors's Core Laboratories position peaked at $5.96M in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Southpoint Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.